Results 91 to 100 of about 666,121 (300)
Prospectively determined clinical T and N categories clearly stratified long‐term survival in locally advanced gastric cancer. Patients with cT3N+, cT4aN0, cT4aN+, and cT4b disease showed unfavorable prognosis despite standard treatment. These findings may help optimize patient selection for perioperative treatment strategies.
Tsutomu Hayashi +19 more
wiley +1 more source
Gastric cancer often carries a poor prognosis, with an estimated 740,000 deaths from the malignancy occurring yearly worldwide (Dicken et al., 2005). The mortality of disease is largely dependent on the extent of tumor spread, as gastric cancer has a ...
Mitanshu Shah +6 more
doaj +1 more source
Many differences in clinicopathological features of gastric cancer and its treatment have been reported between the East and the West however such a comparison using Australian data is still lacking. Gastric cancers seen in Australia differ significantly
Kwon, Sebastianus +11 more
core
AI‐Driven Cancer Multi‐Omics: A Review From the Data Pipeline Perspective
The exponential growth of cancer multi‐omics data brings opportunities and challenges for precision oncology. This review systematically examines AI's role in addressing these challenges, covering generative models, integration architectures, Explainable AI for clinical trust, clinical applications, and key directions for clinical translation.
Shilong Liu, Shunxiang Li, Kun Qian
wiley +1 more source
Aim. The problem of early diagnostic of gastric cancer has a tight connection with the issue of premalignant lesions, especially gastric polyps. The aim of this research was to compare the expression levels of Ki-67, p53 and caspase-3 in epithelial cells
T. A. Khrystenko
doaj +1 more source
Gastric adenocarcinoma–GC (H&E—original magnification 40x).
Gastric adenocarcinoma–GC (H&E—original magnification 40x).
Przemysław Majewski (491153) +5 more
core +1 more source
Relative survival rates (%) in patients with oesophageal squamous cell carcinoma, oesophageal adenocarcinoma, gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma in Sweden in 2000–2008, and follow-up until 2009.
Jesper Lagergren (287652) +1 more
core +1 more source
Tumour-stage specific relative survival rates (%) in patients with oesophageal squamous cell carcinoma, oesophageal adenocarcinoma, gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma in Sweden in 2004–2008, and follow-up until 2009.
Jesper Lagergren (287652) +1 more
core +1 more source
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi +21 more
wiley +1 more source

